Multiple sclerosis in patients of adolescent age

Abstract

Prevalence and incidence of multiple sclerosis (MS) in the childhood and adolescence is not exactly known. Children with MS are estimated between 2,7% to 5,6% of all patients with MS throughout the world.

Keywords

• infantile multiple sclerosis
• juvenile multiple sclerosis
• acute treatment
• diseases modifying therapy
• natalizumab